SCHEMBL5870874

SCHEMBL5870874

CCC(=O)N(CC12CC1CCN(Cc1ccccc1)C2)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.59
OPRM1 P35372 17/20 0.58
SIGMAR1 Q99720 13/20 0.58
KCNH2 Q12809 5/20 0.55
OPRD1 P41143 2/20 0.50
SLC22A1 O15245 1/20 0.47
NR1I2 O75469 1/20 0.47
ABCB1 P08183 1/20 0.47
CHRM1 P11229 1/20 0.47
DRD2 P14416 1/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47
CHRM3 P20309 1/20 0.47
MAOA P21397 1/20 0.47
DRD4 P21917 1/20 0.47
MAOB P27338 1/20 0.47
ADRA1A P35348 1/20 0.47
HRH1 P35367 1/20 0.47
ADRA1B P35368 1/20 0.47
DRD3 P35462 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701119 0.84 OPRM1 (0.56) ACHEOPRM1SIGMAR1KCNH2OPRD1
SCHEMBL7697370 0.79 OPRM1 (0.56) OPRM1SIGMAR1KCNH2OPRD1SLC22A1
SCHEMBL3098485 0.76 ACHE (0.78) ACHEOPRM1SIGMAR1OPRD1
SCHEMBL17137260 0.75 ACHE (0.47) ACHESIGMAR1DRD2CHRM3DRD4
SCHEMBL5870766 0.75 ACHE (0.47) ACHESIGMAR1DRD2CHRM3DRD4
SCHEMBL14601860 0.74 ACHE (1.00) ACHEOPRM1SIGMAR1
SCHEMBL18458663 0.73 SIGMAR1 (1.00) ACHEOPRM1SIGMAR1KCNH2
SCHEMBL6045571 0.73 OPRM1 (1.00) OPRM1SIGMAR1KCNH2OPRD1SLC22A1
SCHEMBL19819957 0.73 ACHE (0.45) ACHESIGMAR1DRD2CHRM3DRD4
Hydrochloric Acid SCHEMBL29651340 0.72 OPRM1 (0.97) OPRM1SIGMAR1KCNH2OPRD1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129228-B2 Heterocyclic analgesic compounds and methods of use thereof SEPRACOR INC. (US) 2006-10-31 US disclosed
US-20040209846-A1 Heterocyclic analgesic compounds and methods of use thereof CUNY GREGORY D (US) 2004-10-21 US disclosed
US-6677332-B1 AMIDE-SUBSTITUTED PIPERIDINE OR AZEPINE DERIVATIVES TO TREAT DRUG ABUSE AND TINNITUS SEPRACOR, INC. 2004-01-13 US disclosed
US-6645980-B1 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals SEPRACOR INC. 2003-11-11 US disclosed
US-6635661-B2 Piperidinyl amide compounds SEPRACOR INC. 2003-10-21 US disclosed
US-20020016337-A1 Heterocyclic analgesic compounds and methods of use thereof SEPRACOR INC. 2002-02-07 US disclosed
WO-2001092226-A1 HETEROCYCLIC ANALGESIC COMPOUNDS AND METHOD OF USE THEREOF SEPRACOR, INC. (US) 2001-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209846-A1 Heterocyclic analgesic compounds and methods of use thereof OPRL1, TRPV1, OPRK1 ACHE 295/4885OPRM1 4/4885SIGMAR1 40/4885
US-20020016337-A1 Heterocyclic analgesic compounds and methods of use thereof OPRL1, TRPV1, OPRK1 ACHE 295/4885OPRM1 4/4885SIGMAR1 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.